IP Library Granted Patent US 9,382,521
Granted Patent B2
US 9,382,521 · App. 13/848,070 · Granted Jul 5, 2016

Polyunsaturated fatty acid production in heterologous organisms using PUFA polyketide synthase systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,382,521
App. No.
13/848,070
Granted
Jul 5, 2016
Kind
B2
Abstract

Disclosed are novel acyl-CoA synthetases and novel acyltransferases, nucleic acid molecules encoding the same, recombinant nucleic acid molecules and recombinant host cells comprising such nucleic acid molecules, genetically modified organisms (microorganisms and plants) comprising the same, and methods of making and using the same. Also disclosed are genetically modified organisms (e.g., plants, microorganisms) that have been genetically modified to express a PKS-like system for the production of PUFAs (a PUFA PKS system or PUFA synthase), wherein the organisms have been modified to express an acyl-CoA synthetase, to express an acyl transferase, to delete or inactivate a fatty acid synthase (FAS) expressed by the organism, to reduce competition for malonyl CoA with the PUFA synthase or to increase the level of malonyl CoA in the organism, and in one aspect, to inhibit KASII or KASIII. Additional modifications, and methods to make and use such organisms, in addition to PUFAs and oils obtained from such organisms, are disclosed, alone with various products including such PUFAs and oils.

Claims (23)

1. A recombinant vector comprising a nucleic acid sequence encoding a protein with triacylglycerol (TAG) synthesis activity, wherein the protein comprises an amino acid sequence that is at least 95% identical to the amino acid sequence of SEQ ID NO: 101.

2. The recombinant vector of claim 1 , wherein the nucleic acid sequence encodes a protein comprising the amino acid sequence of SEQ ID NO: 101.

3. The recombinant vector of claim 1 , wherein the nucleic acid sequence encodes a protein consisting of the amino acid sequence of SEQ ID NO: 101.

4. The recombinant vector of claim 1 , wherein the nucleic acid sequence comprises SEQ ID NO: 100.

5. The recombinant vector of claim 1 , wherein the nucleic acid sequence consists of SEQ ID NO: 100.

6. The recombinant vector of claim 1 , wherein the vector is an expression vector.

7. A recombinant host cell comprising the recombinant vector of claim 1 .

8. The recombinant host cell of claim 7 , wherein the host cell is a microorganism.

9. The recombinant host cell of claim 7 , wherein the host cell is a plant cell.

10. A genetically modified organism, wherein the organism has been genetically with the recombinant vector of claim 1 to express the nucleic acid sequence encoding a protein with TAG synthesis activity, and wherein the organism is a microorganism or a plant.

11. The genetically modified organism of claim 10 , wherein the organism expresses a polyunsaturated fatty acid (PUFA) synthase and a phosphopantetheinyl transferase (PPTase).

12. A recombinant nucleic acid molecule comprising:

(a) a nucleic acid sequence encoding a protein with triacylglycerol (TAG) synthesis activity, wherein the protein comprises an amino acid sequence that is at least 95% identical to the amino acid sequence of SEQ ID NO: 101, and

(b) a heterologous expression control sequence.

13. The recombinant nucleic acid molecule of claim 12 , wherein the nucleic acid sequence of (a) encodes a protein comprising the amino acid sequence of SEQ ID NO: 101.

14. The recombinant nucleic acid molecule of claim 12 , wherein the nucleic acid sequence of (a) encodes a protein consisting of the amino acid sequence of SEQ ID NO: 101.

15. The recombinant nucleic acid molecule of claim 12 , wherein the nucleic acid sequence of (a) comprises SEQ ID NO: 100.

16. The recombinant nucleic acid molecule of claim 12 , wherein the nucleic acid sequence of (a) consists of SEQ ID NO: 100.

17. A recombinant host cell comprising the recombinant nucleic acid molecule of claim 12 .

18. The recombinant host cell of claim 17 , wherein the host cell is a microorganism.

19. The recombinant host cell of claim 17 , wherein the host cell is a plant cell.

20. A genetically modified organism, wherein the organism has been genetically with the recombinant nucleic acid molecule of claim 12 to express the nucleic acid sequence encoding a protein with TAG synthesis activity, and wherein the organism is a microorganism or a plant.

21. The genetically modified organism of claim 20 , wherein the organism expresses a PUFA synthase and a PPTase.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2013
From: METZ, JAMES G.; KUNER, JERRY M.; LIPPMEIER, JAMES CASEY
To: MARTEK BIOSCIENCES CORPORATION
Reel/Frame 030343/0655 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2013
From: MARTEK BIOSCIENCES CORPORATION
To: DSM IP ASSETS B.V.
Reel/Frame 030343/0741 →